Loading company…
Rivaara Labs provides molecular diagnostic testing and point-of-care laboratory services.
Founded in 2019, Rivaara Labs provides molecular diagnostic services and point-of-care testing for doctors and patients. Its tests use DNA analysis and RT-PCR technology, and cover a range of diagnostic needs. The company is based in Mumbai, India. In November 2022, it raised INR 600 million co-led by Amicus Capital and Kotak Investment Advisors, with participation from management.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in